These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7562751)

  • 21. Evaluation of phenytoin in rheumatoid arthritis--an open study.
    Naidu MU; Ramesh Kumar T; Anuradha RT; Rao UR
    Drugs Exp Clin Res; 1991; 17(5):271-5. PubMed ID: 1756690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of two schedules for administering oral low-dose methotrexate (weekly versus every-other-week) in patients with rheumatoid arthritis in remission: a twenty-four week, single blind, randomized study.
    Luis M; Pacheco-Tena C; Cazarín-Barrientos J; Lino-Pérez L; Goycochea MV; Vazquez-Mellado J; Burgos-Vargas R
    Arthritis Rheum; 1999 Oct; 42(10):2160-5. PubMed ID: 10524688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Doxycycline in the treatment of rheumatoid arthritis--a pilot study.
    Sreekanth VR; Handa R; Wali JP; Aggarwal P; Dwivedi SN
    J Assoc Physicians India; 2000 Aug; 48(8):804-7. PubMed ID: 11273473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy and safety of auranofin compared to placebo in rheumatoid arthritis.
    Katz WA; Alexander S; Bland JH; Blechman W; Bluhm GB; Bonebrake RA; Falbo A; Greenwald RA; Hartman S; Hobbs T; Indenbaum S; Lergier JE; Lanier BG; Lightfoot RW; Phelps P; Sheon RP; Torretti D; Wenger ME; Wilske K
    J Rheumatol Suppl; 1982; 8():173-8. PubMed ID: 6813481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multicenter, randomized, double-blind, controlled trial of treatment of active rheumatoid arthritis with T-614 compared with methotrexate.
    Lu LJ; Bao CD; Dai M; Teng JL; Fan W; Du F; Yang NP; Zhao YH; Chen ZW; Xu JH; He PG; Wu HX; Tao Y; Zhang MJ; Han XH; Li XF; Gu JR; Li JH; Yu H
    Arthritis Rheum; 2009 Jul; 61(7):979-87. PubMed ID: 19565542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gold therapy in rheumatoid arthritis. Interim report of the Canadian multicenter prospective trial comparing sodium aurothiomalate and auranofin.
    Menard HA; Beaudet F; Davis P; Harth M; Percy JS; Russell AS; Thompson JM
    J Rheumatol Suppl; 1982; 8():179-83. PubMed ID: 6813482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized, double blind, placebo controlled multicenter trial of murine anti-CD4 monoclonal antibody therapy in rheumatoid arthritis.
    Wendling D; Racadot E; Wijdenes J; Sibilia J; Flipo RM; Cantagrel A; Miossec P; Eschard JP; Macro M; Bertin P; Lioté F; Debiais F; Juvin R; Le Goff P; Masson C
    J Rheumatol; 1998 Aug; 25(8):1457-61. PubMed ID: 9712083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and tolerability of valdecoxib in treating the signs and symptoms of severe rheumatoid arthritis: a 12-week, multicenter, randomized, double-blind, placebo-controlled study.
    Gibofsky A; Rodrigues J; Fiechtner J; Berger M; Pan S
    Clin Ther; 2007 Jun; 29(6):1071-85. PubMed ID: 17692722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ocular side effects of chloroquine in patients with rheumatoid arthritis, systemic lupus erythematosus and scleroderma.
    Leecharoen S; Wangkaew S; Louthrenoo W
    J Med Assoc Thai; 2007 Jan; 90(1):52-8. PubMed ID: 17621733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical effectiveness and tolerance of auranofin in patients with chronic polyarthritis. Results of a multicenter long-term study].
    Klein G; Schwann H; Mirtl B; Thumb N; Mayerhofer F; Singer F; Tausch G; Gaismayer K; Rieder H; Hartweger A
    Z Rheumatol; 1988; 47(5):342-6. PubMed ID: 3149087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sulfasalazine has a better efficacy/toxicity profile than auranofin--evidence from a 5 year prospective, randomized trial.
    McEntegart A; Porter D; Capell HA; Thomson EA
    J Rheumatol; 1996 Nov; 23(11):1887-90. PubMed ID: 8923361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and efficacy of T-614 in the treatment of patients with active rheumatoid arthritis: a double blind, randomized, placebo-controlled and multicenter trial.
    Lü LJ; Teng JL; Bao CD; Han XH; Sun LY; Xu JH; Li XF; Wu HX
    Chin Med J (Engl); 2008 Apr; 121(7):615-9. PubMed ID: 18466681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A 48-week, randomized, double-blind, double-observer, placebo-controlled multicenter trial of combination methotrexate and intramuscular gold therapy in rheumatoid arthritis: results of the METGO study.
    Lehman AJ; Esdaile JM; Klinkhoff AV; Grant E; Fitzgerald A; Canvin J;
    Arthritis Rheum; 2005 May; 52(5):1360-70. PubMed ID: 15880810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can collagen type II sustain a methotrexate-induced therapeutic effect in patients with long-standing rheumatoid arthritis? A double-blind, randomized trial.
    Häuselmann HJ; Caravatti M; Seifert B; Wang K; Bruckner P; Stucki G; Michel BA
    Br J Rheumatol; 1998 Oct; 37(10):1110-7. PubMed ID: 9825751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The moderate intestinal side effects of auranofin do not require prophylactic therapy with a bulkforming agent. Dutch Ridaura Study Group.
    van Beusekom HJ; van de Laar MA; Franssen MJ; van Valburg JA; Gijzel WP; Couvée JE
    Clin Rheumatol; 1997 Sep; 16(5):471-6. PubMed ID: 9348142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A double blind multicentre study of OM-8980 and auranofin in rheumatoid arthritis.
    Vischer TL
    Ann Rheum Dis; 1988 Jul; 47(7):582-7. PubMed ID: 3041924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A long-term five-year randomized controlled trial of hydroxychloroquine, sodium aurothiomalate, auranofin and penicillamine in the treatment of patients with rheumatoid arthritis.
    Jessop JD; O'Sullivan MM; Lewis PA; Williams LA; Camilleri JP; Plant MJ; Coles EC
    Br J Rheumatol; 1998 Sep; 37(9):992-1002. PubMed ID: 9783766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Auranofin (SK&F) in early rheumatoid arthritis: results from a 24-month double-blind, placebo-controlled study. Effect on clinical and biochemical assessments.
    Johnsen V; Borg G; Trang LE; Berg E; Brodin U
    Scand J Rheumatol; 1989; 18(5):251-60. PubMed ID: 2688083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CPH-82 (Reumacon) versus auranofin (Ridaura): a 36-week study of their respective onset of action rates in RA.
    Bjørneboe O; Moen F; Nygaard H; Haavik TK; Svensson B
    Scand J Rheumatol; 1998; 27(1):26-31. PubMed ID: 9506874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5 year followup of a prospective double blind placebo controlled study.
    Egsmose C; Lund B; Borg G; Pettersson H; Berg E; Brodin U; Trang L
    J Rheumatol; 1995 Dec; 22(12):2208-13. PubMed ID: 8835550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.